Literature DB >> 12164371

Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution.

J C H Van der Hilst1, B W Smits, J W M van der Meer.   

Abstract

In this paper, clinical data of 49 adult patients with agammaglobulinaemia (syn. hypogammaglobulinaemia), 15 cases of X-linked agammaglobulinaemia (XLA) and 34 of common variable immunodeficiency (CVID) are reviewed. Although immunoglobulin substitution largely abolished life-threatening respiratory tract infections, considerable infectious and non-infectious morbidity was still encountered in these patients. Almost all patients suffered from chronic or recurrent upper and lower airway infections, mainly caused by Haemophilus influenzae and pneumococci. The lower respiratory tract infections led to cumulative damage to the respiratory tract, especially in XLA patients. Also the incidence of infections outside the respiratory tract (giardiasis, Campylobacter jejuni infections) was more common in XLA patients than in CVID patients. Nodular lymphoid hyperplasia was only found in CVID. A variety of other non-infectious complications were seen especially in CVID. Neoplastic complications occurred in nine patients (two cases of thymoma, two colorectal cancer, one gastric carcinoma, two haematological malignancies, two cases of skin cancer). Six patients died (five XLA patients and one CVID patient, from infectious and non-infectious causes).

Entities:  

Mesh:

Year:  2002        PMID: 12164371

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  33 in total

1.  BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector.

Authors:  H Yamamoto; M Ishimura; M Ochiai; H Takada; K Kusuhara; Y Nakatsu; T Tsuzuki; K Mitani; T Hara
Journal:  Gene Ther       Date:  2015-08-17       Impact factor: 5.250

Review 2.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

Review 3.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Pyoderma gangrenosum-like ulcer in a patient with X-linked agammaglobulinemia: identification of Helicobacter bilis by mass spectrometry analysis.

Authors:  Patrick R Murray; Ashish Jain; Gulbu Uzel; Raymond Ranken; Cristina Ivy; Lawrence B Blyn; David J Ecker; Rangarajan Sampath; Chyi-Chia Richard Lee; Maria L Turner
Journal:  Arch Dermatol       Date:  2010-05

5.  Systemic humoral immunity to non-typeable Haemophilus influenzae.

Authors:  P T King; J Ngui; D Gunawardena; P W Holmes; M W Farmer; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 6.  Integration of B cell responses through Toll-like receptors and antigen receptors.

Authors:  David J Rawlings; Marc A Schwartz; Shaun W Jackson; Almut Meyer-Bahlburg
Journal:  Nat Rev Immunol       Date:  2012-03-16       Impact factor: 53.106

7.  Multiple malignancies in a female patient with common variable immunodeficiency syndrome.

Authors:  Milena Todorovic; Bela Balint; Bosko Andjelic; Biljana Mihaljevic
Journal:  Singapore Med J       Date:  2014-10       Impact factor: 1.858

Review 8.  Gastric adenocarcinoma in the context of X-linked agammaglobulinemia: case report and review of the literature.

Authors:  Aidé Tamara Staines Boone; María Guadalupe Torres Martínez; Gabriela López Herrera; Julia O de Leija Portilla; Sara Elva Espinosa Padilla; Francisco J Espinosa Rosales; Saúl Oswaldo Lugo Reyes
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

Review 9.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

10.  B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia.

Authors:  Hannah M Kerns; Byoung Y Ryu; Brigid V Stirling; Blythe D Sather; Alexander Astrakhan; Stephanie Humblet-Baron; Denny Liggitt; David J Rawlings
Journal:  Blood       Date:  2010-01-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.